ASX Share rice
Sun 16 May 2021 - 07:08:am (Sydney)

IVX Share Price

INVION LIMITEDIVXPharmaceuticals, Biotechnology & Life Sciences

IVX Company Information

Name:

Invion Limited

Sector:

Healthcare

Industry:

Drug Manufacturers-Specialty & Generic

GIC Industry:

Pharmaceuticals

GIC Sub Industry:

Pharmaceuticals

Address:

692 High Street Melbourne VIC Australia 3102

Phone:

61 3 8618 6843

Interim CEO & Exec. Chairman:

Mr. Thian Chew

CFO & Company Sec.:

Ms. Melanie Jaye Leydin C.A., B.Bus, CA

Head of Intellectual Property Devel.:

Dr. Dean Naylor

Company Overview:

Invion Limited, a clinical-stage life-sciences company, researches and develops photodynamic therapy for the treatment of various cancers in Australia. The company is developing IVX-PDT, a chlorophyll-based photosensitizer to treat skin cancers, as well as solid cancers, including lung, prostrate, ovarian, and mesothelioma cancers. It has a research and development agreement with Hudson Institute of Medical Research to collaborate on a range of research and development projects for the Photosoft technology for the treatment of a range of cancers; and research agreement with Peter MacCallum Cancer Centre to undertake pre-clinical and in-vitro studies on Invion's IVX-PDT Photodynamic therapy for ano-genital cancers, including penile and anal cancer. The company was incorporated in 2000 and is headquartered in Melbourne, Australia.

IVX Share Price Information

Shares Issued:

5.54B

Market Capitalisation:

$55.38M

Revenue (TTM):

$2.87M

Revenue Per Share (TTM):

$0

Earnings per Share:

$-0.0002

Profit Margin:

-0.2182

Operating Margin (TTM):

$-0.27

Return On Assets (TTM):

$-0.09

Return On Equity (TTM):

$-0.12

Quarterly Revenue Growth (YOY):

-0.329

Gross Profit(TTM):

$1.92M

IVX CashFlow Statement

CashFlow Date:

2020-06-30

Change To Liabilities:

$-302,853

Net Income:

$-953,894

Total Cash From Operating Activities:

$-152,470

Depreciation:

$277.91K

Change To Account Receivables:

$-74,404

Capital Expenditures:

$0

IVX Income Statement

Income Date:

2020-06-30

Income Before Tax:

$-953,890

Net Income:

$-953,890

Gross Profit:

$3.48M

Operating Income:

$-958,470

Total Revenue:

$3.48M

IVX Balance Sheet

Balance Sheet Date:

2020-06-30

Intangible Assets:

$4.84M

Total Liabilities:

$326.82K

Total Stockholder Equity:

$5.43M

Other Current Liabilities:

$11K

Total Assets:

$5.76M

Common Stock:

$130.56M

Retained Earnings:

$-127,111,711

Cash:

$618.84K

Total Current Liabilities:

$326.82K

Property - Plant & Equipment:

$3.89K

Net Tangible Assets:

$593.93K

Total Current Assets:

$0.92M

Net Receivables:

$271.85K

Short-Term Investments:

$4.84M

Accounts Payable:

$105.67K

Short-Term Investments:

$4.84

Non Current Liabilities Total:

$0

IVX Share Price History

IVX News

28 Feb, 2021
How far off is Invion Limited ( ASX:IVX ) from its intrinsic value? Using the most recent financial data, we'll take a...
01 Sep, 2020
We can readily understand why investors are attracted to unprofitable companies. For example, although...